Aummune vs Impact Biotech
Aummune vs Impact Biotech, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Aummune is on 53/100 and Impact Biotech on 39/100.
Where each one leads
Aummune
- our overall score: 53/100 against 39/100
- funding raised: $10.0M against $2.7M
Impact Biotech
- domain rating: 19/100 against 17/100
- headcount: 42 against 6
- headcount growth: +16.9% against -36.7%
- LinkedIn following: 1,470 against 334
At a glance
| Measure | Aummune | Impact Biotech |
|---|---|---|
| What it is | Develops a platform for individual drug customization using aptamers for cancer treatment. | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. |
| Category | Life Sciences, Cancer, Therapeutics, Biotech | Life Sciences, Cancer, Therapeutics, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2017 | 1996 |
| Headquarters | San Diego, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Aummune | Impact Biotech |
|---|---|---|
| Employees | 6 | 42 |
| Headcount growthLast 12 months | -36.7% | +16.9% |
| Total funding | $10.0M | $2.7M |
| Latest round | Series A | Grant |
| LinkedIn followers | 334 | 1,470 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Aummune | Impact Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 39/100 |
| Traction | 43/100 | 49/100 |
| Team | 80/100 | Not published |
| Search visibility | 29/100 | 34/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 17/100 | 19/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Aummune | Impact Biotech |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Aummune vs Impact Biotech: common questions
Which is better, Aummune or Impact Biotech?
On our 0-100 score Aummune rates higher (53/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Aummune and Impact Biotech compare on the numbers?
Aummune leads on our overall score (53/100 against 39/100), funding raised ($10.0M against $2.7M). Impact Biotech leads on domain rating (19/100 against 17/100), headcount (42 against 6), headcount growth (+16.9% against -36.7%), LinkedIn following (1,470 against 334).
Read the full Aummune review and pricing or the Impact Biotech review and pricing. You can also browse other Aummune alternatives we track.